AtriCure, Inc.
ATRC
$33.31
$0.551.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 16.55% | 17.56% | 17.57% | 18.70% | 20.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.55% | 17.56% | 17.57% | 18.70% | 20.84% |
| Cost of Revenue | 19.12% | 18.72% | 17.34% | 14.81% | 17.10% |
| Gross Profit | 15.70% | 17.17% | 17.65% | 20.03% | 22.13% |
| SG&A Expenses | 14.91% | 18.85% | 16.12% | 13.01% | 9.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.53% | 19.45% | 18.91% | 16.48% | 14.29% |
| Operating Income | -47.68% | -51.39% | -38.28% | 6.04% | 36.50% |
| Income Before Tax | -46.33% | -54.36% | -41.76% | 2.49% | 35.39% |
| Income Tax Expenses | 73.27% | 233.63% | 153.25% | 140.00% | 120.52% |
| Earnings from Continuing Operations | -46.85% | -56.81% | -43.11% | 1.40% | 34.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.85% | -56.81% | -43.11% | 1.40% | 34.49% |
| EBIT | -47.68% | -51.39% | -38.28% | 6.04% | 36.50% |
| EBITDA | -73.26% | -78.38% | -37.63% | 29.34% | 60.33% |
| EPS Basic | -44.87% | -54.97% | -41.15% | 2.84% | 35.39% |
| Normalized Basic EPS | -37.93% | -44.64% | -33.01% | 6.42% | 35.43% |
| EPS Diluted | -44.87% | -54.97% | -40.64% | 3.10% | 35.53% |
| Normalized Diluted EPS | -37.93% | -44.64% | -33.01% | 6.42% | 35.43% |
| Average Basic Shares Outstanding | 1.42% | 1.34% | 1.29% | 1.26% | 1.24% |
| Average Diluted Shares Outstanding | 1.42% | 1.34% | 1.29% | 1.26% | 1.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
